Literature DB >> 5579906

Obstructive airway disease in patients with treated pulmonary tuberculosis.

G L Snider, L Doctor, T A Demas, A R Shaw.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5579906     DOI: 10.1164/arrd.1971.103.5.625

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  38 in total

1.  COPD in India: Iceberg or volcano?

Authors:  Arvind B Bhome
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

Review 2.  Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence.

Authors:  E Hnizdo; V Vallyathan
Journal:  Occup Environ Med       Date:  2003-04       Impact factor: 4.402

3.  Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment.

Authors:  E Hnizdo; T Singh; G Churchyard
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

4.  Expression of toll-like receptor 2 and plasma level of interleukin-10 are associated with outcome in tuberculosis.

Authors:  J-Y Wang; H-C Chang; J-L Liu; C-C Shu; C-H Lee; J-T Wang; L-N Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-17       Impact factor: 3.267

5.  Clinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.

Authors:  Avradip Santra; Pravati Dutta; Rekha Manjhi; Sudarsan Pothal
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 6.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

Review 7.  Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease.

Authors:  Biswajit Chakrabarti; Peter M A Calverley; Peter D O Davies
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

8.  Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.

Authors:  Jung-Yien Chien; Shun-Tien Chien; Wei-Yih Chiu; Chong-Jen Yu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 9.  Platelet Activation and the Immune Response to Tuberculosis.

Authors:  Daniela E Kirwan; Deborah L W Chong; Jon S Friedland
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.